SCHEMBL12415416

SCHEMBL12415416

Cc1cnc(COS(C)(=O)=O)c(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
SMO Q99835 5/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
XBP1 P17861 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TLR9 Q9NR96 1/20 0.32
SCN9A Q15858 2/20 0.32
PTGS2 P35354 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16728654 0.86 PLAU (0.34) TDP1L3MBTL1GAAPKMALDH1A1
SCHEMBL6490655 0.85 L3MBTL1 (0.40) TRPM8TDP1L3MBTL1GAAPKM
SCHEMBL6501465 0.80 ALDH1A1 (0.38) TDP1L3MBTL1GAAPKMALDH1A1
SCHEMBL1722950 0.79 L3MBTL1 (0.58) TDP1L3MBTL1GAAPKMALDH1A1
SCHEMBL6487877 0.76 NPC1 (0.39) NPC1HSD17B10
SCHEMBL25283521 0.74 PTGDR2 (0.33) ALDH1A1NPC1HSD17B10KMT2A
SCHEMBL22493674 0.73 PLAU (0.34) L3MBTL1PTGS2
SCHEMBL30486626 0.73 PLAU (0.34) L3MBTL1PTGS2
SCHEMBL6497617 0.71 MAPKAPK2 (0.41)
SCHEMBL17943829 0.71 S1PR4 (0.36) TDP1L3MBTL1MAPTHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110172236-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS CHAKRAVARTY PRASUN K 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172236-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS TRPV1, TRPA1, CACNA1D TRPM8 22/4885TDP1 3914/4885L3MBTL1 4377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.